Phase 4Recruiting

Time to Loss of Consciousness With Remimazolam Versus Propofol for Anesthetic Induction in Laparoscopic Cholecystectomy (REMIPROP-LOC)

Time to Loss of Consciousness With Remimazolam Versus Propofol During Anesthetic Induction for Laparoscopic Cholecystectomy: A Single-Center Randomized Controlled Trial

Sponsor
Universidade Federal de Sergipe (Academic or other)
Enrollment
66 planned
Conditions
Intravenous Anesthesia; Cholelithiasis
Interventions
Remimazolam; Propofol
Ages
adults
Registry
NCT07717684

Full record on ClinicalTrials.gov

From the registry

The goal of this clinical trial is to compare two medicines used to induce general anesthesia in adults undergoing elective laparoscopic cholecystectomy. The study aims to determine whether remimazolam leads to a different time to loss of consciousness than propofol. The main question it aims to answer is: Does remimazolam change the time to loss of consciousness compared with propofol during anesthesia induction? Researchers will compare remimazolam with propofol to evaluate the time required for participants to lose consciousness. The study will also compare blood pressure, heart rate, and other safety outcomes during anesthesia induction. Participants will: * Be randomly assigned to receive either remimazolam or propofol for anesthesia induction. * Receive standard monitoring and anesthesia care throughout surgery. * Have their time to loss of consciousness, vital signs, and any adverse events recorded during the induction period.

Primary outcomes

  • Time to Loss of Consciousness (TLOC)

History

  1. Primary completion expected

  2. Last registry update

  3. Started

  4. Registered